These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38537426)

  • 1. Does hyperphenylalaninemia induce brain glucose hypometabolism? Cerebral spinal fluid findings in treated adult phenylketonuric patients.
    Trefz F; Frauendienst-Egger G; Dienel G; Cannet C; Schmidt-Mader B; Haas D; Blau N; Himmelreich N; Spraul M; Freisinger P; Dobrowolski S; Berg D; Pilotto A
    Mol Genet Metab; 2024 May; 142(1):108464. PubMed ID: 38537426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the brain barrier system function and changes of cerebrospinal fluid concentrations of phenylalanine and tyrosine in human phenylketonuria.
    Ratzmann GW; Grimm U; Jährig K; Knapp A
    Biomed Biochim Acta; 1984; 43(2):197-204. PubMed ID: 6732755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Content of phenylalanine, tyrosine and their metabolites in CSF in phenylketonuria.
    Antoshechkin AG; Chentsova TV; Tatur VYu ; Naritsin DB; Railian GP
    J Inherit Metab Dis; 1991; 14(5):749-54. PubMed ID: 1779620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria.
    Ney DM; Hull AK; van Calcar SC; Liu X; Etzel MR
    J Nutr; 2008 Feb; 138(2):316-22. PubMed ID: 18203898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high-protein meal plus aspartame ingestion on plasma phenylalanine concentrations in obligate heterozygotes for phenylketonuria.
    Curtius HC; Endres W; Blau N
    Metabolism; 1994 Apr; 43(4):413-6. PubMed ID: 8159095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
    Gropper SS; Yannicelli S; White BD; Medeiros DM
    Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular phenylalanine and tyrosine concentration in homozygotes and heterozygotes for phenylketonuria (PKU) and hyperphenylalaninemia compared with normals.
    Thalhammer O; Lubec G; Königshofer H; Scheibenreiter S; Coradello H
    Hum Genet; 1982; 60(4):320-1. PubMed ID: 7106768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid biogenic amines depletion and brain atrophy in adult patients with phenylketonuria.
    Pilotto A; Blau N; Leks E; Schulte C; Deuschl C; Zipser C; Piel D; Freisinger P; Gramer G; Kölker S; Haas D; Burgard P; Nawroth P; Georg H; Scheffler K; Berg D; Trefz F
    J Inherit Metab Dis; 2019 May; 42(3):398-406. PubMed ID: 30706953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future role of large neutral amino acids in transport of phenylalanine into the brain.
    Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
    Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
    Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage induced by phenylalanine and its analogue p-chlorophenylalanine in blood and brain of rats subjected to a model of hyperphenylalaninemia.
    Simon KR; Dos Santos RM; Scaini G; Leffa DD; Damiani AP; Furlanetto CB; Machado JL; Cararo JH; Macan TP; Streck EL; Ferreira GC; Andrade VM; Schuck PF
    Biochem Cell Biol; 2013 Oct; 91(5):319-24. PubMed ID: 24032682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria.
    Pietz J; Kreis R; Rupp A; Mayatepek E; Rating D; Boesch C; Bremer HJ
    J Clin Invest; 1999 Apr; 103(8):1169-78. PubMed ID: 10207169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations of blood and brain biochemistry in phenylketonuria: Results from the Pah-enu2 PKU mouse.
    Dijkstra AM; van Vliet N; van Vliet D; Romani C; Huijbregts SCJ; van der Goot E; Hovens IB; van der Zee EA; Kema IP; Heiner-Fokkema MR; van Spronsen FJ
    Mol Genet Metab; 2021 Nov; 134(3):250-256. PubMed ID: 34656426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Of mice and men: Plasma phenylalanine reduction in PKU corrects neurotransmitter pathways in the brain.
    Berguig GY; Martin NT; Creer AY; Xie L; Zhang L; Murphy R; Pacheco G; Bullens S; Olbertz J; Weng HH
    Mol Genet Metab; 2019 Dec; 128(4):422-430. PubMed ID: 31648944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria.
    Leuzzi V; Bianchi MC; Tosetti M; Carducci CL; Carducci CA; Antonozzi I
    J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy.
    Pietz J; Rupp A; Ebinger F; Rating D; Mayatepek E; Boesch C; Kreis R
    Pediatr Res; 2003 Apr; 53(4):654-62. PubMed ID: 12612190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untreated PKU Patients without Intellectual Disability: What Do They Teach Us?
    van Vliet D; van Wegberg AMJ; Ahring K; Bik-Multanowski M; Casas K; Didycz B; Djordjevic M; Hertecant JL; Leuzzi V; Mathisen P; Nardecchia F; Powell KK; Rutsch F; Stojiljkovic M; Trefz FK; Usurelu N; Wilson C; van Karnebeek CD; Hanley WB; van Spronsen FJ
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31731404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.